Thursday plan: keep the AI leader book intact as rates test selective growth
Hold MSFT, AMZN, NVDA, and META at current weights for Thursday. Large-cap technology leadership remains constructive, but weak breadth, rising rate pressure, and AMZN's deterioration argue against adding risk at the open.
Grade: B. The prior plan beat SPY, but the result was mixed: MSFT and META rose while AMZN and NVDA fell.
Since Last Session
On Wednesday, MSFT gained 0.52% and META gained 1.02%. NVDA fell 1.47%, while AMZN declined 2.24%. The prior book lost 0.44% versus SPY's 0.72% decline.
Regime Check
Regime: R2. Growth leadership remains selective rather than broad. Large-cap technology still has positive medium-term momentum, but rates and weak participation outside the leading franchises limit the case for increasing exposure.
Supporting: QQQ has 3.20% 20-day momentum and 3.98% 60-day momentum. MSFT, NVDA, and META retain positive momentum across both periods, and the VIX stands at 15.18. AI and compute spending remain central to equity leadership.
Contradicting: TLT fell 1.58% Wednesday and has negative momentum over both measured periods. IWM has negative 20-day and 60-day momentum, while XLF is also negative across both periods. News flow points to hot inflation, a possible October Fed hike, and a 19-year high in the 10-year Treasury yield.
Plan for Thursday
No portfolio changes are planned at the open. The book will remain concentrated in MSFT, AMZN, NVDA, and META at existing weights. Wednesday's relative result supports continuity, while AMZN's weakness is already reflected in its smaller position and lower conviction score.
The open must confirm that demand for MSFT, NVDA, and META remains firmer than the broad market and that AMZN's weakness isn't spreading across cloud and internet leaders. A rate-driven decline across all four holdings, paired with continued weakness in QQQ and broader participation, would require a fresh risk review rather than an automatic price-based trade.
Positioning
| Holding | Weight | Thesis state | Action | Evidence |
|---|---|---|---|---|
| MSFT | 29% | STRENGTHENED | Hold | Gained 0.52% Wednesday, with positive 20-day momentum and 9.52% 60-day momentum. |
| AMZN | 19% | WEAKENED | Hold at the book's smallest weight | Fell 2.24% Wednesday, with negative 20-day and 60-day momentum. |
| NVDA | 28% | INTACT | Hold | Fell 1.47% Wednesday, but 20-day and 60-day momentum remain positive. |
| META | 24% | STRENGTHENED | Hold without adding | Gained 1.02% Wednesday and retains 15.95% 20-day momentum and 21.32% 60-day momentum. |
The portfolio remains fully invested. MSFT and NVDA represent 57% of the book, keeping the largest exposure in enterprise AI, cloud infrastructure, and accelerated computing. META supplies the strongest current momentum. AMZN remains the monitored weak link.
Institutional Signals
Institutional filings support concentration, but they don't settle Thursday's decision. Pershing Square reported substantial positions in AMZN and MSFT in its May filing. Bridgewater's August filing included NVDA alongside large broad-market ETF positions. Berkshire's August filing also showed that a high-conviction manager can remain concentrated in a small set of durable businesses.
These filings are slow-moving context. They support patience with established theses, but AMZN's recent deterioration still demands current operating evidence before any increase.
What Could Break It
- A sustained rate shock that keeps pressuring TLT and begins to reverse leadership across QQQ, MSFT, NVDA, and META.
- Azure growth decelerating for two consecutive quarters while Microsoft continues to raise capital spending.
- A top-three hyperscaler cutting or deferring 2027 capital spending, or NVDA gross-margin guidance weakening because of custom-silicon substitution.
- AWS growth slowing while Amazon's capital spending rises, with no improvement in monetization or North American retail operating margin.
- META's consumer AI adoption failing to produce durable advertising or subscription growth, or regulatory constraints materially impairing product adoption.